Crowdonomics
All companies

Emerald Health Pharmaceuticals Inc.

Operating

San Diego, CA

Latest valuation
—
No round has disclosed a priced valuation or cap.
Total raised
$0
Across 1 round since 2021
Latest share price
$8.00
Reg A Offering (2021) offering price

Financials

FY2020 · from SEC filings · hover any figure for its source
$0
−$12.4M
2020
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 audited
Income statement
Revenue
$0
Cost of goods sold
$11,961,268
Net income
-$12,424,622
Balance sheet
Cash
$17,036,840
Accounts receivable
$513,953
Total assets
$21,092,332
Long-term debt
$0
Total liabilities
$8,441,635
Other
Headcount
18

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited; no pill means the filing didn’t state one. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Fundraising history

Reg A Offering (2021)ClosedReg A+ · Equity · via DALMORE GROUP LLC
Raised $0 / $50M

Team

9 people
James DeMesa
President and Chief Executive Officer
Alain Rolland
Chief Operating Officer
Eduardo Muñoz
Chief Scientific Officer
Joachim Schupp
Chief Medical Officer
Lisa Sanford
Chief Financial Officer
Nancy Coulson
Senior Vice President Regulatory and Quality Affairs
James L. Heppell
Director and Chairman
Gaetano A. Morello
Director
Punit S. Dhillon
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

SEC filings

View all 30 filings on EDGAR
  • Form 1-UMar 19, 20240001213900-24-023617
    EDGAR
  • Form 1-UApr 28, 20230001213900-23-033573
    EDGAR
  • Form 1-UMar 24, 20230001213900-23-022816
    EDGAR
  • Form 1-UOct 28, 20220001213900-22-067163
    EDGAR
  • Form 1-SASep 30, 20220001213900-22-060310
    EDGAR
  • Form 1-UAug 19, 20220001213900-22-049712
    EDGAR
  • Form 1-UJul 28, 20220001213900-22-042435
    EDGAR
  • Form 1-UJul 8, 20220001213900-22-038234
    EDGAR
Source: SEC EDGARCIK 0001700800DEShare price $8.00Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.